Interlab ends a year of success marked by development and growth, crowned by the launch of version 7 of Its software
Interlab, a leading company in traceability and management of surgical instruments and medical devices, concludes 2024 as an exceptional year, marked by significant technological advancements, impactful contributions to the medical community, and continuous growth on a global scale.
The launch of version 7 of its traceability software was the year’s most notable milestone. This tool, which redefines standards of traceability, efficiency, and accuracy in hospital management, has transformed how surgical resources are managed in real time. Its main features include:
Speed and Power: Workflow optimization to increase productivity and reduce response times.
Intuitive Interface: User-friendly design enabling real-time tracking of instruments and medical devices.
Multi-Platform Access: Responsive design compatible with multiple browsers, offering flexible access.
Full Integration: Capability to work with other hospital systems, reducing errors and improving data cohesion.
This advancement supports compliance with national and international standards, such as those of the Joint Commission International (JCI), enables hospitals to achieve ISO certifications, and positions Interlab at the forefront as a reference in technological innovation for the healthcare sector.
A Year of Expansion and Consolidation
In 2024, Interlab expanded its reach to users in 10 countries and strengthened its international presence by participating in prominent events in Mexico, Costa Rica, Brazil, Argentina, Panama, the United States, Spain, Colombia, Ecuador, Uruguay, and Peru, among others. At these events, the company offered lectures and workshops highlighting the importance of digitalization and traceability in hospital management, benefiting doctors, instrument technicians, and industry leaders.
Additionally, Interlab forged new strategic alliances that boosted its growth and enhanced its services, always aiming to reinforce its commitment to innovation and excellence.
Commitment to Quality and Innovation
This year was also marked by the ISO recertification process, a fundamental step reaffirming the high-quality standards that define Interlab. This effort, combined with the dedication of its highly skilled team, ensures that its software meets the highest standards of quality and safety, strengthening client trust and optimizing hospital processes.
“2024 was an exceptional year for Interlab. Our commitment to innovation and excellence has allowed us to establish ourselves as a benchmark in the healthcare sector, bringing our solutions to new markets and benefiting the global medical community. We are ready to continue innovating in 2025,” said the company’s director, Ezequiel Giuliani.
Looking Ahead
With a focus on 2025, Interlab will continue to drive transformation in the healthcare sector, offering technological tools that simplify complexity, improve the management of medical resources, and enhance the quality of care worldwide.
For more information, visit: www.interlabd.com